Abstract: Unique compounds useful for inhibiting a proteasome in a cell, pharmaceutical compositions and methods of their use are provided herein.

Abstract: A cover window for a display device includes: a first film; a second film on the first film; and an adhesive layer between the first film and the second film. The adhesive layer has a lap shear modulus in a range of 20 kPa to 50 kPa.

Abstract: The present disclosure relates to a composition for producing tagatose, comprising fructose-6-phosphate-4-epimerase, and a method of producing tagatose using the same.

Abstract: The present disclosure relates to novel D-psicose 3-epimerase and a method for producing psicose using the same.

Abstract: Provided is a novel compound derived from allulose and a composition comprising the same and having acid resistance.

Abstract: An exemplary embodiment provides a cover window for a display device, including: a first film; a second film disposed on the first film; and an adhesive layer disposed between the first film and the second film, wherein the adhesive layer includes an elastic polymer, and wherein a ratio of a thickness of the second film to a thickness of the first film is in a range of 0.2 to 5.

Abstract: A cover window for a display device includes: a first film; a second film on the first film; and an adhesive layer between the first film and the second film. The adhesive layer has a lap shear modulus in a range of 20 kPa to 50 kPa.

Abstract: The present application relates to a method for producing D-psicose, the method comprising the steps of: putting a composition containing a D-psicose borate complex into a chromatography comprising divalent cations; and separating the composition containing the D-psicose borate complex into a D-psicose-containing fraction (i) and a borate-containing fraction (ii).

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: The present invention relates to a composition for preventing and treating muscle diseases or improving muscular function, containing a Platycodon grandiflorum extract. More specifically, the present invention relates to: a pharmaceutical composition for preventing and treating muscle diseases, containing a Platycodon grandiflorum extract; a food composition for preventing muscle diseases or improving muscular function; or a cosmetic for improving muscular function. The Platycodon grandiflorum extract of the present invention increases muscle formation by inducing muscular protein synthesis and muscle cell differentiation. Therefore, the extract is a natural product so as to be used safely without side effects, thereby being usable as an active ingredient of a pharmaceutical, food, or cosmetic composition exhibiting an excellent effect in preventing and treating muscle diseases or improving muscular function.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: The disclosure relates a display apparatus comprising: a signal input receiver receives a plurality of signals which are different in kind from each other, a plurality of encoders provided respectively corresponding to the plurality of signals, and perform encoding of a corresponding mode according to the kinds of at least one signal input to the signal input receiver among the plurality of signals, a first interface transmits a signal obtained by serializing the encoded signal, a second interface deserializes the signal received from the first interface, a plurality of decoders provided respectively corresponding to the plurality of encoders, and perform decoding and restoring the deserialized signal into the at least one signal, and a display displays an image based on the at least one restored signal.

Abstract: Disclosed herein is a method of producing D-psicose. The method of producing D-psicose includes subjecting D-fructose to D-psicose epimerization to produce a D-psicose-containing solution, subjecting the D-psicose-containing solution to first cooling and ion purification, subjecting the purified D-psicose-containing solution to first concentration and second cooling, subjecting the D-psicose-containing solution, which has been subjected to first concentration and second cooling, to chromatography to obtain a D-fructose-containing mother liquor and a D-psicose-containing separated solution, and subjecting the D-psicose-containing separated solution to second concentration and third cooling to obtain D-psicose crystals, wherein the D-fructose-containing mother liquor produced by chromatography is reused in the D-psicose epimerization.

Abstract: The present disclosure relates to fructose-6-phosphate-3-epimerase consisting of an amino acid sequence of SEQ ID NO: 1, a nucleic acid encoding the fructose-6-phosphate-3-epimerase, and a transformant comprising the nucleic acid. Additionally, the present disclosure relates to a composition for producing allulose, which comprises the fructose-6-phosphate-3-epimerase of the present disclosure, and a method for producing allulose using the fructose-6-phosphate-3-epimerase of the present disclosure.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: The present disclosure relates to tagatose-6-phosphate phosphatase consisting of an amino acid sequence of SEQ ID NO: 1, a nucleic acid encoding the tagatose-6-phosphate phosphatase, and a transformant comprising the nucleic acid. Additionally, the present disclosure relates to a composition for producing tagatose, which comprises the tagatose-6-phosphate phosphatase of the present disclosure, and a method for producing tagatose using the tagatose-6-phosphate phosphatase of the present disclosure.

Abstract: The present disclosure relates to a method for preparing a transglucosylated steviol glycoside using a crude enzyme liquid of a Lactobacillus mali strain.

Abstract: Provided is a novel compound derived from allulose and a composition comprising the same and having acid resistance.

Abstract: The present invention relates to a health functional food for inhibiting a rise of blood glucose containing coffee and tagatose.

Abstract: The present invention relates to a novel high-temperature active thermoresistant polyphosphate-dependent glucokinase with high thermal stability, a composition including the enzyme, and methods for producing glucose 6-phosphate using the enzyme.